Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy
Intrauterine Adhesions Prevention: the Use of Heparin Solution Compared to Application of Anti-adhesion Barrier Gel After Operative Hysteroscopy
Nadezhda Women's Health Hospital
100 participants
Feb 14, 2022
INTERVENTIONAL
Conditions
Summary
The aim of this study is to compare the efficacy of intrauterine application of heparin solution to the use of hyaluronic acid barrier gel for the prevention of intrauterine adhesion formation after operative hysteroscopy.
Eligibility
Inclusion Criteria8
- female sex
- indication for operative hysteroscopy including one or more of the following:
- infertility,
- irregular bleeding,
- oligo-/amenorrhea,
- Asherman syndrome,
- G0-G3 fibroids,
- dysmorphic uterus.
Exclusion Criteria4
- ongoing pregnancy,
- genital cancer,
- pelvic inflammatory disease,
- excessive uterine bleeding.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
3 ml saline solution containing 5000 IU heparin.
2 ml biodegradable barrier gel containing sodium hyaluronate (10 mg/ml), sodium chloride (8.5 mg/ml), disodium hydrogen phosphate (0.34mg/ml), sodium dihydrogen phosphate (0.14 mg/ml) and water for injection (QS to weight).
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05257213